Large-cap Health Care company ResMed has logged a -2.8% change today on a trading volume of 844,074. The average volume for the stock is 1,644,378.
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. Based in San Diego, United States the company has 10,140 full time employees and a market cap of $20,961,081,344. ResMed currently offers its equity investors a dividend that yields 1.2% per year.
The company is now trading -22.55% away from its average analyst target price of $184.0 per share. The 8 analysts following the stock have set target prices ranging from $165.0 to $220.0, and on average give ResMed a rating of buy.
Over the last 12 months RMD shares have declined by -38.0%, which represents a difference of -49.0% when compared to the S&P 500. The stock's 52 week high is $243.52 per share and its 52 week low is $136.02. Based on ResMed's average net margin growth of 4.2% over the last 6 years, its core business remains strong and the stock price may recover in the long term.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2022-08-12 | 3,578,127 | 779,437 | 22 | 46.67 |
| 2021-08-17 | 3,196,825 | 474,505 | 15 | -28.57 |
| 2020-08-13 | 2,957,013 | 621,674 | 21 | 31.25 |
| 2019-08-08 | 2,606,572 | 404,592 | 16 | 23.08 |
| 2018-08-17 | 2,340,196 | 315,588 | 13 | -23.53 |
| 2017-08-04 | 2,066,737 | 342,284 | 17 |
